Schwann cell differentiation

Current Opinion in Cell Biology

Volumn 8, Issue 6, 1996, Pages 870-876

  Zorick, Todd S ^a,b   Lemke, Greg ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; NEUROREGULIN; POLYPEPTIDE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SPECIFICITY; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; MOUSE; MYELINATION; NEURAL CREST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SCHWANN CELL; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION REGULATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0030560863     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80090-1     Document Type: Article

References (53)

1. Lemke G. Myelin and myelination. Hall Z. An Introduction to Molecular Neurobiology. 1992;281-309 Sinauer, Sunderland, Massachusetts.
2. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet. 11:1995;274-280.
3. Sereda M, Griffiths I, Puhlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
4. Koenig HL, Schumacher M, Ferzaz B, Thi AN, Ressouches A, Guennoun R, Jung-Testas I, Robel P, Akwa Y, Baulieu EE. Progesterone synthesis and myelin formation by Schwann cells. Science. 268:1995;1500-1503.
5. Saada A, Reichert F, Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol. 133:1996;159-167.
6. 2A receptors on cultured rat Schwann cells. Glia. 17:1996;15-27.
7. Mirsky R, Jessen KR. Schwann cell development, differentiation, and myelination. Curr Opin Neurobiol. 6:1996;89-96.
8. Lemke G. Neuregulins in development. of special interest Mol Cell Neurosci. 7:1996;247-262 This is a comprehensive review of the history and role of neuregulins and their receptors in mammalian development, including a discussion of the recent knockouts in the mouse NRG, ErbB2, and ErbB4 genes.
9. Shah NM, Marchionni MA, Isaacs I, Stroobant P, Anderson DJ. Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell. 77:1994;349-360.
10. Jin JJ, Nikitin A, Rajewsky MF. Schwann cell lineage-specific neu (erbB-2) gene expression in the developing rat nervous system. Cell Growth Differ. 4:1993;227-237.
11. Jessen KR, Brennan A, Morgan L, Mirsky R, Kent A, Hashimoto Y, Gavrilovic J. The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron. 12:1994;509-527.
12. + Schwann cell precursors, indicating that neuregulin receptor signaling is important for early generation of the Schwann cell lineage.
13. Dong Z, Brennan A, Liu N, Yarden Y, Lefkowitz G, Mirsky R, Jessen KR. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. of special interest Neuron. 15:1995;585-596 As a follow-up to [11], the authors show that neuregulins are also capable of preventing apoptosis of Schwann cell precursors, stimulating their division, and causing their maturation.
14. Morrissey TK, Levi AD, Nuijens A, Sliwkowski MX, Bunge RP. Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. of special interest Proc Natl Acad Sci USA. 92:1995;1431-1435 Using human Schwann cells cultured in the presence of neuregulins, the authors show that signaling through the ErbB2 NRG receptor is essential for mitogenesis.
15. Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, Sliwkowski MX. The influence of heregulins on human Schwann cell proliferation. J Neurosci. 15:1995;1329-1340.
16. Cheng L, Mudge AW. Cultured Schwann cells constitutively express the myelin protein P0. Neuron. 16:1996;309-319.
17. Offenhauser N, Bohm-Matthaei R, Tsoulfas P, Parada L, Meyer M. Developmental regulation of full-length trkC in the rat sciatic nerve. Eur J Neurosci. 7:1995;917-925.
18. Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Lindsay RM, Yancopoulos GD. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron. 5:1990;501-509.
19. Schumacher M, Jung-Testas I, Robel P, Baulieu EE. Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP. Glia. 8:1993;232-240.
20. Gavrilovic J, Brennan A, Mirsky R, Jessen KR. Fibroblast growth factors and insulin growth factors combine to promote survival of rat Schwann cell precursors without induction of DNA synthesis. of special interest Eur J Neurosci. 7:1995;77-85 Using their previously described cultured E14 Schwann cell precursors, the authors show a potentiation of the ability of FGFs to rescue apoptotic death when combined with IGFs, implicating IGFs as survival factors for embryonic Schwann cell culture.
21. Cheng H-L, Randolph A, Yee D, Delafontaine P, Tennekoon G, Feldman EL. Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. of special interest J Neurochem. 66:1996;525-536 Increased expression of Schwann cell generated IGF-I and the IGF-I receptor is observed upon adult peripheral nerve lesion. IGF-I is shown to be a mitogenic factor for cultured neonatal Schwann cells, and the IGF-I receptor is detected in vitro.
22. 0 expression. When grown in the presence of IGFs and FGF, TGF-β, PDGF, or neuregulins, a potentiated mitogenic response is seen in the absence of myelin-specific gene expression.
23. Flanders KC, Lüdecke G, Engels S, Cissel DS, Roberts AB, Kondaiah P, Lafyatis R, Sporn MB, Unsicker K. Localization and actions of transforming growth factor-βs in the embryonic nervous system. Development. 113:1991;183-191.
24. Unsicker K, Flanders KC, Cissel DS, Lafyatis R, Sporn MB. Transforming growth factor beta isoforms in the rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
25. Morgan L, Jessen KR, Mirsky R. Negative regulation of the P0 gene in Schwann cells: suppression of P0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGF beta 1, TGF beta 2 and TGF beta 3. Development. 120:1994;1399-1409.
26. Guenard V, Gwynn LA, Wood PM. Transforming growth factor-beta blocks myelination but not ensheathment of axons by Schwann cells in vitro. of special interest J Neurosci. 15:1995;419-428 See annotation [27].
27. Einheber S, Hannocks MJ, Metz CN, Rifkin DB, Salzer JL. Transforming growth factor-beta 1 regulates axon/Schwann cell interactions. of special interest J Cell Biol. 129:1995;443-458 Two groups [26,27] demonstrate that in a Schwann cell: DRG neuronal coculture system, exogenous TGF-β prevents myelination, decreases the expression of myelin-specific gene products, and causes Schwann cells to adopt a nonmyelinating-like phenotype in vitro.
28. Guenard V, Rosenbaum T, Gwynn LA, Doetschman T, Ratner N, Wood PM. Effect of transforming growth factor-beta 1 and -beta 2 on Schwann cell proliferation on neurites. Glia. 13:1995;309-318.
29. Stitt TN, Conn G, Gore M, Lai C, Bruno J, Radziejewski C, Mattsson K, Fisher J, Gies DR, Jones PF, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. of outstanding interest Cell. 80:1995;661-670 The authors demonstrate that Gas6 is a ligand for Tyro 3, and that both molecules are expressed in Schwann cells in vitro.
30. Li R, Chen J, Hammonds G, Phillips H, Armanini M, Wood P, Bunge R, Godowski PJ, Sliwkowski MX, Mather JP. Identification of Gas6 as a growth factor for human Schwann cells. of special interest J Neurosci. 16:1996;2012-2019 The authors demonstrate the physiological relevance of Gas6 and Tyro 3 to Schwann cells, both in vitro by showing the mitogenic effect of Gas6 on cultured Schwann cells, and in vivo by showing the developmental expression of Gas6 mRNA in peripheral neurons.
31. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci. 14:1991;453-501.
32. Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J. 6:1992;2450-2455.
33. Syroid DE, Maycox PR, Burrola PG, Liu N, Wen D, Lee K-F, Lemke G, Kilpatrick TJ. Cell death in the Schwann cell lineage and its regulation by neuregulin. of special interest Proc Natl Acad Sci USA. 93:1996;9229-9234 Apoptosis is shown to occur during the normal development of postnatal rodent peripheral nerve Schwann cells. In vitro, neonatal Schwann cells undergo apoptosis upon serum withdrawal. This apoptosis can be prevented by addition of NRGs to serum-free medium.
34. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, Scherer SS. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. of special interest J Neurosci. 1996; The authors demonstrate that apoptosis occurs in vivo in sciatic nerve Schwann cells during the first two weeks of postnatal development, that sciatic nerve axotomy caused increased apoptosis in distal nerve stumps of newborn animals, but not in adult animals which are rescued by in vivo GGF2 infusion, and that neonatal sciatic nerve Schwann cells express phosphorylated forms of the ErbB2 and ErbB3 NRG receptors.
35. Trachtenberg JT, Thompson WJ. Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. of special interest Nature. 379:1996;174-177 In contrast to in adults, denervation of neonatal nerve terminals is shown to result in Schwann cell apoptosis, which is prevented by the in vivo infusion of NRG (GGF), implicating NRG as an axonal survival factor for neonatal terminal Schwann cells.
36. Ciutat D, Caldero J, Oppenheim RW, Esquerda JE. Schwann cell apoptosis during normal development and after axonal degeneration induced by neurotoxins in the chick embryo. of special interest J Neurosci. 16:1996;3979-3990 In embryonic chick peripheral nerves, Schwann cell apoptosis is shown to occur during the normal course of development, and is increased in extent after experimentally induced axonal degeneration, indicating that in vivo embryonic Schwann cell apoptosis is regulated by axons.
37. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde YA. Selective activation of NF-kappa B by nerve growth factor through the neutrophin receptor p75. of special interest Science. 272:1996;542-545 Cultured neonatal Schwann cells are found to express the transcription factor NF-κB, which is translocated to the nucleus by addition of NGF to the culture medium. This response is dependent on Schwann cell expression of the LNGFR.
38. Stewart HJ. Expression of c-Jun, Jun B, Jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro. Eur J Neurosci. 7:1995;1366-1375.
39. Kioussi C, Gross MK, Gruss P. Pax3: a paired domain gene as a regulator in PNS myelination. Neuron. 15:1995;553-562.
40. Nikam SS, Tennekoon GI, Christy BA, Yoshino JE, Rutkowski JL. The zinc finger transcription factor Zif268/Egr-1 is essential for Schwann cell expression of the p75 NGF receptor. Mol Cell Neurosci. 6:1995;337-348.
41. Monuki ES, Weinmaster G, Kuhn R, Lemke G. SCIP: a glial cell POU domain gene regulated by cyclic AMP. Neuron. 3:1989;783-793.
42. Monuki ES, Kuhn R, Weinmaster G, Trapp BD, Lemke G. Expression and activity of the POU transcription factor SCIP. Science. 249:1990;1300-1303.
43. Monuki ES, Kuhn R, Lemke G. Repression of the myelin P0 gene by the POU transcription factor SCIP. Mech Dev. 42:1993;15-32.
44. Scherer SS, Wang DY, Kuhn R, Lemke G, Wrabetz L, Kamholz J. Axons regulate Schwann cell expression of the POU transcription factor SCIP. J Neurosci. 14:1994;1930-1942.
45. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature. 371:1994;796-799.
46. Swiatek PJ, Gridley T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev. 7:1993;2071-2084.
47. Messing A, Behringer RR, Hammang JP, Palmiter RD, Brinster RL, Lemke G. Po promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice. Neuron. 8:1992;507-520.
48. Weinstein DE, Burrola PG, Lemke G. Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP. of outstanding interest Mol Cell Neurosci. 6:1995;212-229 Schwann cell specific expression of a dominant-negative transgene to ablate SCIP function results in mice with a hypermyelinating neuropathy, characterized by prematurely myelinating Schwann cells and aberrant myelination.
49. Meijer D, Graus A, Grosveld G. Mapping the transactivation domain of the Oct-6 POU transcription factor. Nucleic Acids Res. 20:1992;2241-2247.
50. Monuki ES, Kuhn R, Lemke G. Cell-specific action and mutable structure of a transcription factor effector domain. Proc Natl Acad Sci USA. 90:1993;9978-9982.
51. Jaegle M, Mandemakers W, Broos L, Zwart R, Karls A, Visser P, Grosveld F, Meijer D. The POU factor Oct-6 and Schwann cell differentiation. of outstanding interest Science. 273:1996;507-510 See annotation [52].
52. -/- Schwann cells eventually myelinate more or less normally.
53. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci. 8:1996;. in press.